Tradestie Institutional Equity Comparison Engine

NBP vs ANRO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ANRO Overall Edge

ANRO Captures Institutional Edge (3โ€“1 Pillars ยท 3โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alto Neuroscience Inc. (ANRO) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while NBP counters with relative strength in Valuation. Fundamentally, NBP trades at 2.7x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ANRO at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NBP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ANRO sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NBP
NBP 2.7x vs ANRO N/M Fwd P/E
Growth & Margin Winner ANRO
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner ANRO
1Y -81.0% vs +143.0% ยท 52W Pos 0% vs 63%
Options & Structure Winner ANRO
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (8th %ile IV)
NBP US Equity
NBP
Institutional Equity
$0.79
-6.66% 1D
Market Cap $96.3M
1M Return -37.04%
1Y Return -80.98%
Forward P/E 2.7x
Unified AI Score
51.9 / 100 HOLD
Tech 60.0 Fund 50.0 Flow 50.0 Mom 55.0
ANRO NYSE
Alto Neuroscience Inc.
Pharmaceutical Preparations
$27.59
-6.62% 1D
Market Cap $1.2B
1M Return +25.73%
1Y Return +143.04%
Forward P/E N/M
Unified AI Score
29.3 / 100 SELL
Tech 50.0 Fund 34.0 Flow 65.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NBP -80.98% ANRO +143.04% Spread: +224.02 pp (ANRO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NBP TTM Op. Margin: 0.0% ANRO TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NBP vs ANRO. Trailing 12-month operating profitability (NBP 0.0% vs ANRO 0.0%) and valuation multiples (NBP 2.7x vs ANRO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NBP (4) vs ANRO (3)
Institutional Metric NBP ANRO Criterion Row Winner
Market Capitalization Scale $96.3M $1.2B Larger Scale ANRO
Trailing P/E Ratio Valuation 2.7x N/M Lower Multiple NBP
Forward P/E Ratio Valuation 2.7x N/M Lower Multiple NBP
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -59.1% -46.7% Higher ROE ANRO
52-Week Range Position Momentum 0% ($1โ€“$5) 63% ($11โ€“$37) Stronger Trend ANRO
Beta / 30D Volatility Risk Regime 1.66ฮฒ ยท 81% Vol 1.95ฮฒ ยท 89% Vol Lower Realized Risk NBP
Unified Institutional Score Composite Signal 51.9 / 100 (HOLD) 29.3 / 100 (SELL) Higher Composite NBP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NBP vs ANRO Buy Guide
NBP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NBP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ANRO CONSOLIDATION
57d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live ANRO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NBP nor ANRO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.